Evogene shares are trading lower after the company received a letter from the Nasdaq indicating that the company is not in compliance with the minimum bid price rule.
Portfolio Pulse from Benzinga Newsdesk
Evogene has received a letter from Nasdaq stating that the company is not in compliance with the minimum bid price rule, leading to a decrease in its share price.
September 21, 2023 | 2:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Evogene's stock price is falling due to a non-compliance notice from Nasdaq regarding the minimum bid price rule.
Evogene's non-compliance with Nasdaq's minimum bid price rule has led to a decrease in its share price. This negative news could continue to put downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100